CryoPort Inc (NASDAQ:CYRX) has received an average broker rating score of 1.25 (Strong Buy) from the four brokers that provide coverage for the company, Zacks Investment Research reports. One investment analyst has rated the stock with a buy rating and three have issued a strong buy rating on the company.
Brokers have set a 1 year consensus target price of $11.20 for the company and are anticipating that the company will post ($0.09) EPS for the current quarter, according to Zacks. Zacks has also assigned CryoPort an industry rank of 59 out of 265 based on the ratings given to related companies.
Several research analysts have recently issued reports on the company. Needham & Company LLC restated a “buy” rating and issued a $11.00 price objective (up from $10.00) on shares of CryoPort in a research note on Thursday. Roth Capital assumed coverage on CryoPort in a research note on Thursday, November 30th. They set a “buy” rating and a $12.50 price objective on the stock.
CryoPort (CYRX) traded up $0.01 during mid-day trading on Wednesday, reaching $9.97. The company’s stock had a trading volume of 110,264 shares, compared to its average volume of 126,619. CryoPort has a twelve month low of $1.96 and a twelve month high of $10.40. The stock has a market capitalization of $272.31, a price-to-earnings ratio of -28.49 and a beta of 0.71.
CryoPort (NASDAQ:CYRX) last posted its quarterly earnings results on Tuesday, March 6th. The consumer goods maker reported ($0.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.02). CryoPort had a negative return on equity of 48.53% and a negative net margin of 66.09%. The firm had revenue of $3.33 million for the quarter, compared to the consensus estimate of $3.37 million. CryoPort’s revenue for the quarter was up 49.5% on a year-over-year basis. equities analysts forecast that CryoPort will post -0.25 earnings per share for the current year.
TRADEMARK VIOLATION NOTICE: This story was first published by Ticker Report and is the property of of Ticker Report. If you are accessing this story on another publication, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this story can be viewed at https://www.tickerreport.com/banking-finance/3253601/brokerages-set-11-20-target-price-for-cryoport-inc-cyrx.html.
CryoPort Company Profile
Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.